Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.

Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.

Item
http://www.wikidata.org/entity/Q33905311
The Application of Natural Killer Cell Immunotherapy for the Treatment of CancerManufacturing Natural Killer Cells as Medicinal ProductsRevving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.Adoptive Cell Therapy in Multiple Myeloma.The antileukemic potential of natural killer cells.Engineering Natural Killer Cells for Cancer Immunotherapy.In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients.Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma.IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced FunctionTriKEs and BiKEs join CARs on the cancer immunotherapy highway.Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer.Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells.Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesOptimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
P2860

Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.

Item
http://www.wikidata.org/entity/Q33905311
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expansion and homing of adopti ...... ications for clinical therapy.
@ast
Expansion and homing of adopti ...... ications for clinical therapy.
@en
type
label
Expansion and homing of adopti ...... ications for clinical therapy.
@ast
Expansion and homing of adopti ...... ications for clinical therapy.
@en
prefLabel
Expansion and homing of adopti ...... ications for clinical therapy.
@ast
Expansion and homing of adopti ...... ications for clinical therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Expansion and homing of adopti ...... ications for clinical therapy.
@en
P2093
P2860
P304
P31
P356
10.1016/J.BBMT.2014.05.004
P433
P478
P50
P577
P5875
P698
P932